Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer—regional differences in efficacy
@article{APM103007, author = {Rutika Mehta and Manish A. Shah}, title = {Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer—regional differences in efficacy}, journal = {Annals of Palliative Medicine}, volume = {11}, number = {10}, year = {2022}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/103007} }